Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric I. Richman currently holds 15,000 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric I. Richman has been a net seller of NBSE stock. They have purchased $315.7K and sold $750.5K worth of shares.
Eric I. Richman's most recent insider trade was on Jun 24, 2024, when they sold 15,000 shares at $0.00 per share.
Eric I. Richman serves as Executive at NeuBase Therapeutics, Inc. (NBSE). They have executed 54 insider transactions totaling $1.1M over their tenure at the company.
Eric I. Richman holds the position of Executive at NeuBase Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Eric I. Richman has shown a selling trading pattern, with $315.7K in total purchases and $750.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric I. Richman was on Nov 22, 2016, when they sold $465.6K worth of PIP shares. This transaction involved 240,000 shares at $1.94 per share.
Eric I. Richman currently owns 15,000 shares of NeuBase Therapeutics, Inc. (NBSE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric I. Richman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric I. Richman has 54 Form 4 filings on record as an insider at NeuBase Therapeutics, Inc..
Set alerts for Eric I. Richman and 40,000+ other insiders.